Yayujing Medical (06929.HK) released its interim results, reporting a profit attributable to shareholders of USD 21.569 million, a year-on-year increase of 9.0%. The interim dividend is 8 HK cents.

Zhitong Finance APP reported that Yaju Medical (06929.HK) announced its interim results for the six months ended June 30, 2026. The groups revenue was $98.707 million, a year-on-year increase of 18.1%; profit attributable to shareholders was $21.569 million, a year-on-year increase of 9.0%; basic earnings per share were 2.62 cents; and the interim dividend was 8 Hong Kong cents.